home / stock / ckpt / ckpt articles

CKPT Articles, Checkpoint Therapeutics Inc. - From 04/08/24

Stock Information
Company Name: Checkpoint Therapeutics Inc.
Stock Symbol: CKPT
Market: NASDAQ
Website: checkpointtx.com
Menu
CKPT CKPT Quote CKPT Short CKPT News CKPT Articles CKPT Message Board
Get CKPT Alerts

News, Short Squeeze, Breakout and More Instantly...
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Checkpoint Therapeutics, Inc. (CKPT) | Benzinga

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in th...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CKPT | Benzinga

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics,...

Class Action Lawsuit Filed on Behalf of Checkpoint Therapeutics, Inc. (CKPT) Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm | Benzinga

ATLANTA, April 08, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint...

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Checkpoint Therapeutics, Inc. (CKPT) | Benzinga

SAN DIEGO, April 07, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons an...
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors | Benzinga

WALTHAM, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy an...

Pinterest, Checkpoint Therapeutics And 2 Other Stocks Insiders Are Selling | Benzinga

The Nasdaq 100 closed higher by around 300 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders sell share...

Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market | Benzinga

WALTHAM, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy and...
Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference | Benzinga

WALTHAM, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy and...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Checkpoint Therapeutics, Inc. - CKPT | Benzinga

NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Checkpoint Therapeutics, Inc. ("Chec...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Checkpoint Therapeutics, Inc. - CKPT | Benzinga

NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of Checkpoint Therapeutics, Inc. ("Checkpoint" or t...
Previous 10 Next 10